Clinical profile of ChAdOx1 nCoV-19- and BBV152-vaccinated individuals among hospitalized COVID-19 patients: a pair-matched study
Background: COVID-19 infections among severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-vaccinated individuals are of clinical concern, especially in those requiring hospitalization. Such real-world data on ChAdOx1 nCoV-19- and BBV152-vaccinated individuals are scarce. Hence, there is an...
Saved in:
Main Authors: | Vishakh C. Keri (Author), Bharathi Arunan (Author), Parul Kodan (Author), Manish Soneja (Author), Neeraj Nischal (Author), Ashwin Varadarajan (Author), Akansha Didwania (Author), Brunda R.L (Author), Anivita Aggarwal (Author), Pankaj Jorwal (Author), Arvind Kumar (Author), Animesh Ray (Author), Prayas Sethi (Author), Ved Prakash Meena (Author), Puneet Khanna (Author), Akhil Kant Singh (Author), Richa Aggarwal (Author), Kapil Dev Soni (Author), Alpesh Goyal (Author), Animesh Das (Author), Anjan Trikha (Author), Naveet Wig (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunogenicity of SARS-CoV-2 vaccines BBV152 (COVAXIN®) and ChAdOx1 nCoV-19 (COVISHIELD™) in seronegative and seropositive individuals in India: a multicentre, nonrandomised observational studyResearch in context
by: Mangaiarkarasi S. Asokan, et al.
Published: (2024) -
A Computational Approach for Molecular Characterization of Covaxin (BBV152) and Its Ingredients for Assessing Its Efficacy against COVID-19
by: Atala B. Jena, et al.
Published: (2022) -
Contact tracing in the hospital setting for COVID-19: An experience from AIIMS, New Delhi
by: Devashish Desai, et al.
Published: (2022) -
Effectiveness of the BBV-152 and AZD1222 vaccines among adult patients hospitalized in tertiary hospitals in Odisha with symptomatic respiratory diseases: A test-negative case-control study
by: Debdutta Bhattacharya, et al.
Published: (2023) -
Vaccine-associated complications: a comparative multicenter evaluation among dental practitioners and dental students-which candidate vaccine is more safe in SARS COV II, Gam-COVID-Vac (Sputnik V), ChAdOx1 nCoV-19 (AstraZeneca), BBV152 (Covaxin), or BBIBP-CorV(Sinopharm)?
by: Behzad Houshmand, et al.
Published: (2022)